Skip to main content

Multi-track investment for CordenPharma

CDMO CordenPharma is planning to invest heavily in all its platforms in terms of both capacities and capabilities, according to Dr Stephen Houldsworth, global head of platform management and marketing, who spoke with SCM at CPhI Worldwide in Milan.

In high potency, Houldsworth said, the firm has just signed off on an expansion of its development capabilities at Plankstadt in Germany. It is also expanding high potency capsule manufacture, where before Plankstadt was mostly focused on tablets, while adding hot melt extrusion to address bioavailability challenges.

Flow chemistry first for Seqens

Seqens will produce the first volumes of an aromatic diamine monomer by means of flow chemistry in its dedicated workshop at SeqensLab in Porcheville, France (pictured), by the end of 2021. This follows a successful first pilot trial in 2020.

Asahi Glassplant buys Syrris

Asahi Glassplant UK has acquired Syrris, a supplier of flow chemistry and jacketed reactor systems, and also scientific glass company Glass Solutions from Blacktrace Holdings of Royston.
Subscribe to flow chemistry